Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-021441

SVP, Head of Global Commercial acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Porter Derrell SVP, Head of Global Commercial 2019-03-26 Grant or award +10,000 31,688 D: show line 1 in the form
Loading xslF345X03/doc4.xml…